Cinacalcet Hydrochloride Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 30 mg 60 mg 90 mg
Reference Brands: Sensipar,Cinacalcet (EU & US)
Category:
Nephrology
Cinacalcet Hydrochloride Tablets are used to manage secondary hyperparathyroidism in chronic kidney disease (CKD) patients, especially those on dialysis, by regulating parathyroid hormone (PTH) levels. It helps improve calcium and phosphate balance, reducing the risk of bone disease and vascular calcification.
Cinacalcet Hydrochloride is available in Tablet
and strengths such as 30 mg 60 mg 90 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Cinacalcet Hydrochloride is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Cinacalcet Hydrochloride can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Cinacalcet Hydrochloride Tablets are a calcimimetic medication used to treat secondary hyperparathyroidism in chronic kidney disease (CKD) patients, particularly those on dialysis. By increasing the sensitivity of calcium-sensing receptors, Cinacalcet helps regulate parathyroid hormone (PTH) levels, improving calcium and phosphate balance. It is essential for managing bone disease and reducing the risk of vascular calcification in dialysis-dependent patients. Available for B2B distribution in the US and EU, Cinacalcet Hydrochloride offers a vital therapeutic solution for nephrology, providing effective management of hyperparathyroidism and contributing to improved outcomes in CKD patients.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing